ACRV: Acrivon Therapeutics, Inc. Stock

by  •  • Comments Off on ACRV: Acrivon Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 56.75
Enterprise Value ($M) 16.93
Book Value ($M) 176.79
Book Value / Share 5.64
Price / Book 0.32
NCAV ($M) 161.83
NCAV / Share 5.16
Price / NCAV 0.35

Profitability (mra)
Return on Invested Capital (ROIC) -0.45
Return on Assets (ROA) -0.67
Return on Equity (ROE) -0.75

Liquidity (mrq)
Quick Ratio 10.55
Current Ratio 10.55

Balance Sheet (mrq) ($M)
Current Assets 181.63
Assets 196.59
Liabilities 19.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -89.20
Net Income -80.56

Cash Flow Statement (mra) ($M)
Cash From Operations -65.67
Cash from Investing -51.77
Cash from Financing 121.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
07-10 13G/A Chione Ltd 17.30 -0.21
2024-04-15 13G/A Perceptive Advisors Llc 17.40 78.23
2024-04-11 13D/A Ra Capital Management, L.p. 27.10 73.52

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-21 90,598 300,495 30.15
2025-04-17 46,246 221,217 20.91
2025-04-16 215,692 574,884 37.52

(click for more detail)

Similar Companies
ACET – Adicet Bio, Inc. ACIU – AC Immune SA
ADMA – ADMA Biologics, Inc. AFMD – Affimed N.V.


Financial data and stock pages provided by
Fintel.io